Search

everythinglearnresearchcommunity

for

Search:↓

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Birth control pills can help manage acne, but dermatologists should know their skin-related side effects, especially when prescribing drugs that can harm unborn babies.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Minoxidil in breast milk may harm nursing infants.

Women with PCOS have more emotional and body image issues than healthy women.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Delayed ejaculation is a complex issue caused by psychological, biological, and lifestyle factors, requiring a holistic treatment approach.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Both genetic and lifestyle factors significantly affect female hair loss.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

The report described a unique case of Cronkhite-Canada syndrome with unusual polyps and an association with multiple myeloma.

Dutasteride does not impair mental function in elderly men with enlarged prostate.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Obesity increases the risk of skin infections, inflammatory conditions, and melanoma, but not basal cell carcinoma.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

Oriental herbal medicine with moxibustion may improve pregnancy rates and other symptoms in PCOS, but more high-quality research is needed.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.